Topical 5-Fluorouracil 1% As First-Line Therapy For Giant Ocular Surface Squamous Neoplasia: Short-Term Outcomes

Published 2023 - 41st Congress of the ESCRS

Reference: PP02.01 | DOI: 10.82333/jk26-qj36